Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Growth 2024-2030

Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Growth 2024-2030

This kit is used for in vitro qualitative detection of EGFR, KRAS, BRAF, PIK3CA gene mutations and ALK, ROS1 gene fusions in 10% neutral formalin-fixed paraffin-embedded tissue (FFPE) samples of patients with non-small cell lung cancer, including EGFR gene L858R, T790M, G719A, S768I, EGFR gene exon 19 deletion, KRAS gene G12V/C/D/R/A/S, G13D mutations, BRAF gene V600E mutation, PIK3CA gene E545K, H1047R mutations and ALK, ROS1 gene fusions. Among them, EGFR exon 19 deletion (19del) and L858R point mutation are used for companion diagnosis of gefitinib tablets and icotinib hydrochloride tablets, EGFR T790M point mutation is used for companion diagnosis of osimertinib mesylate tablets, ALK gene fusion (rearrangement) and ROS1 gene fusion (rearrangement) are used for companion diagnosis of crizotinib capsules.

The global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Forecast” looks at past sales and reviews total world Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales for 2024 through 2030. With Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.

United States market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit players cover Jinqirui Biotechnology, Hangzhou Lianchuan Gene, Xiamen Feishuo Biotechnology, Novogene, Burning Rock, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sequencing Method
Fluorescence PCR Method
Other

Segmentation by Application:
Clinical
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Jinqirui Biotechnology
Hangzhou Lianchuan Gene
Xiamen Feishuo Biotechnology
Novogene
Burning Rock
Shihe Medical
Qiuzhen Medical
Yuanma Gene
BGI
AmoyDx
HLB PanaGene
TRUPCR

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market?

What factors are driving Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market opportunities vary by end market size?

How does Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.